Flu Vaccine Storage and Rotation - Notice of Intent to Sole Source
ID: CDC-2025-88238Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Refrigerated Warehousing and Storage (493120)

PSC

SUPPORT- MANAGEMENT: OTHER (R799)

Original Source

https://sam.gov/opp/b25dc1a71b3c4a5c81d43cfdf6374067/view
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to Seqirus USA Inc. for the storage and rotation of influenza vaccine stockpiles. This procurement aims to ensure the availability of pediatric vaccines manufactured by Seqirus USA Inc. in the national stockpile, which is critical for responding to potential disease outbreaks or vaccine shortages. Interested parties may express their interest and capability to fulfill this requirement, with all responses considered by the government within fifteen days of the notice's issuance. Quotations should be submitted via email to the contract specialist at uuu0@cdc.gov by close of business on October 22, 2024.

    Point(s) of Contact
    Aminah A. Gary
    (404) 498-3206
    uuu0@cdc.gov
    David Dombeck
    (770) 488-2695
    ddombeck@cdc.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Flu Vaccine Storage and Rotation - Notice of Intent to Sole Source
    Currently viewing
    Presolicitation
    Similar Opportunities
    Injectable Egg-Free Influenza Vaccine
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support is seeking suppliers for an Injectable Egg-Free Influenza Vaccine for the upcoming 2025-2026 flu season, with an estimated requirement of approximately 280,000 doses. The vaccine must be FDA-approved for individuals aged 18 and older, and the successful contractor will need to ensure that the vaccine is ACIP recommended, with specific delivery schedules outlined for the ordered quantities. This procurement is critical for maintaining public health and readiness, and interested vendors should prepare for the solicitation SPE2DP-24-R-0006, expected to be issued around October 18, 2024, with further details available on the DLA Bid Board System and SAM.gov. For inquiries, contact Yu Chen at yu.chen@dla.mil or call 215-737-2103.
    Injectable Influenza Vaccine
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency Troop Support, is soliciting offers for the procurement of an Injectable Influenza Vaccine under solicitation SPE2DP24R0003 and Amendment 0001. This contract aims to secure a reliable supply of influenza vaccines, which are critical for maintaining the health and readiness of military personnel. Interested vendors should note that the offer due date is set for October 23, 2024, at 3:00 PM local time, and they can reach out to Kevin Weintraub at kevin.weintraub@dla.mil or Yu Chen at yu.chen@dla.mil for further inquiries.
    Combined Synopsis/Solicitation for Illumina Maintenance Service
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source firm fixed-price contract for maintenance services of Illumina NovaSeq 6000 and MiSeq sequencing instruments. The procurement aims to ensure the availability of manufacturer-approved repair and maintenance services, which are critical for supporting outbreak studies and public health emergencies, with a performance period from December 7, 2024, to December 6, 2025. This contract is essential for the CDC's Genomic Sequencing Laboratory (GSL) to maintain high-quality operations, particularly during times of increased demand for sequencing services. Interested parties must submit their proposals to James Brown III at xvn8@cdc.gov by 12:00 P.M. EDT on October 21, 2024, with an estimated contract value of $144,910.12.
    2025 Southern Hemisphere Influenza Vaccine
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is soliciting proposals for the 2025 Southern Hemisphere Influenza Vaccine. This procurement aims to secure the necessary biological products to support immunization efforts for the upcoming influenza season. The vaccines are critical for public health and military readiness, ensuring that personnel are protected against seasonal influenza strains. Interested vendors can reach out to Rosbert Jones at rosbert.jones@dla.mil or 215-737-2380, or Yu Chen at yu.chen@dla.mil or 215-737-2103 for further details regarding the solicitation process.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    FMD Vaccine Sources Sought
    Active
    Agriculture, Department Of
    The U.S. Department of Agriculture, specifically the Animal and Plant Health Inspection Service, is conducting a sources-sought notice to identify manufacturers capable of producing, storing, and delivering Foot and Mouth Disease (FMD) vaccines. The USDA aims to enhance its vaccine preparedness by acquiring sufficient quantities of FMD vaccines or vaccine precursors to support response activities in the event of an outbreak, focusing on both inactivated products and novel vaccine platforms. This initiative is critical for safeguarding the U.S. livestock industry from the severe economic and health impacts of FMD, with responses due by 1:00 PM EST on October 25, 2024. Interested parties should submit their capability statements to Amanda Imlach at amanda.imlach@usda.gov and Charmion Harris at charmion.harris@usda.gov.
    NIOSH Cincinnati Waste & Recycling
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking quotations for waste and recycling services at the National Institute for Occupational Safety and Health (NIOSH) campus in Cincinnati, Ohio. The procurement aims to secure a certified waste management contractor to manage waste and recycling across three NIOSH buildings, ensuring compliance with local, state, and federal regulations while promoting sustainability efforts. This contract, which will be awarded as a Firm Fixed Price to the lowest price technically acceptable proposal, has a base period from November 3, 2024, to November 2, 2025, with four optional one-year extensions available until November 2, 2029. Interested contractors must submit their quotations by October 15, 2024, and can direct inquiries to Linda Nowak at lnowak@cdc.gov or Mark Draluck at mdraluck@cdc.gov.
    Sources Sought (SS) | World Trade Center Health Program | Survivor Clinical Center of Excellence
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking information from organizations interested in supporting the operationalization of a Clinical Center of Excellence (CCE) as part of the World Trade Center (WTC) Health Program. The objective is to identify potential contractors capable of providing monitoring and treatment services for eligible Survivor members affected by the September 11 terrorist attacks, with services required from July 1, 2025, to June 30, 2030. This initiative underscores the federal commitment to delivering comprehensive healthcare to 9/11 responders and survivors, ensuring compliance with regulations and effective management of healthcare services. Interested parties must submit their capability statements by October 16, 2024, to Melissa Lera at umt1@cdc.gov, as the government evaluates market capacity and may set aside the requirement for small businesses based on responses.
    Waste Removal and Recycling Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified contractors to provide waste removal and recycling services at the National Institute for Occupational Safety and Health (NIOSH) facilities located in Morgantown, West Virginia. The procurement includes weekly domestic waste removal and monthly single stream recycling services, with the contractor responsible for all associated costs, including dumpster rental and transportation. This contract is crucial for maintaining operational efficiency and compliance with environmental standards, and it emphasizes inclusivity by adhering to Section 508 of the Rehabilitation Act. The Request for Quotations (RFQ) is expected to be released at the end of November 2024, with a firm-fixed price contract spanning from February 1, 2025, to January 31, 2030, and interested small businesses should direct inquiries to Joseph Butkus at jbutkus@cdc.gov.
    6505-- Duplex Antibiotic Supply IV Bags
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting quotes for Duplex Antibiotic Supply IV Bags through solicitation number 36C26225Q0028. This procurement aims to establish a base contract for one year, with four additional option years, for the supply of specific pharmaceutical products, including Cefazolin and Ceftriaxone, which are critical for patient care in the VA healthcare system. The total estimated contract value ranges from $150,000 to $300,000, reflecting the VA's variable annual purchasing needs, with the period of performance set from January 1, 2025, through December 31, 2029. Interested vendors must be registered in the System for Award Management (SAM) and are encouraged to submit questions via email by October 8, 2024, to the Contract Specialist, Melissa Ramirez, at Melissa.Ramirez8@va.gov.